May 2024 - Page 3 of 10 - NetworkNewsWire

FridayMay 24, 2024 10:30 am

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), JV Partner Report New Exploration Targets at Storm Project Amid Rising Copper Prices

Preliminary interpretation of initial MLEM survey results indicates new exploration targets highlighting excellent potential to discover additional copper mineralization Copper process projected to continue upward trend Results open “a whole new space for potential discovery,” says Aston Bay CEO As copper prices climb to a 2024 high, Aston Bay Holdings (TSX.V: BAY) (OTCQB: ATBHF) is reporting initial results from geophysical activities that are currently underway at its Nunavut-based Storm Copper Project (https://nnw.fm/ZmXdD). According to the report, preliminary interpretation of the initial moving loop electromagnetic (“MLEM”) survey results indicates several new exploration targets highlighting excellent potential to discover additional copper mineralization. “Soaring…

FridayMay 24, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy

Clene recently participated in the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House Call Virtual Conference, and the Virtual A.G.P. Healthcare Conference CNM-Au8(R) is oral suspension developed to restore neuronal health and function by increasing energy production and utilization The therapy has been involved in clinical trials and compassionate use programs, accumulating over 600 years of exposure across various neurodegenerative conditions, with no safety concerns reported Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease, recently…

FridayMay 24, 2024 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

PaxMedica has received an urgent plea from the Ministry of Health of Malawi for emergency access to IV suramin to prevent a potential humanitarian crisis due to dwindling supplies of essential drugs used to save lives in the region PaxMedica has previously concluded a Type B meeting with the FDA in preparation for the NDA submission, focusing on the use of PAX-101 in treating the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, transmitted by tsetse flies PaxMedica also aims to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide…

ThursdayMay 23, 2024 12:00 pm

DealFlow Events Presents the 5th Annual Reg A & Crowdfunding Conference June 20, 2024

The 5th Annual Reg A & Crowdfunding Conference will take place at New York’s luxurious Westchester Country Club on June 20 The fifth annual conference will play host to investors, entrepreneurs and financiers as we to delve into the latest trends within the equity capital markets industry This year’s conference will feature a number of keynote presentations and speakers, including on topics such as the structuring and efficient marketing of Reg A+ and Crowdfunding deals Learn from (and network with) experts who raise capital with these powerful tools Equity capital markets have long been an attractive source of growth capital…

ThursdayMay 23, 2024 11:15 am

4th Annual Psychedelic Therapeutics and Drug Development Conference Comes to Boston, MA

Researchers and leaders in academia, industry, the non-profit sector, and government organizations are invited to attend the 4th Annual Psychedelic Therapeutics and Drug Development Conference being held May 23-24, 2024, in Boston, MA. The conference focuses on discussing the hurdles as well as challenges in the research and development of psychedelics for various health conditions. Join the experts for this two-day conference that involves exploration, learning, discussion, and networking. Specific areas of discussion will include: Targets for novel drug development Toxicology studies and considerations The dosage debate and new evidence Second generation psychedelic drug design FDA regulatory guidance The speaker…

ThursdayMay 23, 2024 10:30 am

DGE 8th Digital Strategy & Innovation for Medical Affairs To Open New Pathways of Transformation

DGE invites medical affairs and healthcare professionals to attend the 8th Digital Strategy & Innovation For Medical Affairs summit in Philadelphia on June 5-6, 2024. Experts attending the conference will offer insights to leverage digital technology for building patient and caregiver relationships, and for maintaining market position. The summit is organized by Dynamic Global Events (“DGE”), a life science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharma, biotechnology, healthcare, medical devices, and allied industries. The event agenda covers: Incorporating AI into patient outreach Identifying the most important tools needed to…

ThursdayMay 23, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Releases Q1 2024 Financial Results Reflecting ‘Outstanding Growth’

SenesTech reported record Q1 2024 revenue of $415,000, an increase of 78% compared to Q1 2023 and a 41% sequential increase from Q4 2023 The company attributes this growth to the introduction in January 2024 of Evolve(TM), its soft-bait product featuring breakthrough, next-generation technology that targets rat populations by using non-lethal methods to restrict fertility SenesTech is anticipating additional growth following the completion of an efficacy study providing data requested by certain state and international regulators, as this could open new markets that were previously inaccessible In May, the company also launched Evolve(TM) Mouse, a soft-bait product to control mouse…

ThursdayMay 23, 2024 9:00 am

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

The HealthLynked platform provides secure and quick access for patient/doctor records communication, supporting all types of health related utilization, including telemedicine and remote student applications University health clinics often face challenges when transferring medical records – and this limits coordinated care for students The HealthLynked platform provides a streamlined approach to medical records access, allowing students to securely share their health information with relevant parties HealthLynked (OTCQB: HLYK) is a company on a mission to build a superior healthcare system through the efficient integration of patient histories, genetic data, and demographic insights, into a sophisticated AI-driven platform that streamlines patient…

WednesdayMay 22, 2024 10:30 am

DGE 4th PRC Performance Optimization Summit To Unite The Best Minds In The Business

Life science professionals responsible for promotional review, marketing, labelling, communications, and compliance are invited to attend DGE’s 4th PRC Performance Optimization Summit being held in Philadelphia June 5-6, 2024. The most detailed industry event available on this subject, participants will focus in-depth on ways to ensure the best regulatory outcomes. DGE (Dynamic Global Events), a life science leader in organizing B2B events, strives to meet the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. DGE events specialize in offering a robust platform where professionals can network, connect, and explore business opportunities in a…

WednesdayMay 22, 2024 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Reports Record Profit, 400% YoY EBITDA Growth in Q1 2024

SuperCom Ltd. is dedicated to serving government security needs for electronic tracking and monitoring of offenders The company recently reported its quarterly financial results, noting significant growth in revenues, profits, EBITDA, and operating income While SuperCom has focused on acquiring clients in California and other U.S. states, the company also has an international presence, European clients comprising significant part of its business SuperCom (NASDAQ: SPCB) is widening its competitive edge in the electronic monitoring sector, resulting in revenue growth and a record profit for the company, reflected in the company’s recently released Q1 financial report (https://nnw.fm/UBQ13). "The substantial growth in…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: May 2024